- Trials with a EudraCT protocol (419)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
419 result(s) found for: Pain Intensity Assessment.
Displaying page 2 of 21.
EudraCT Number: 2006-004514-40 | Sponsor Protocol Number: KF5503/33-R331333-PAI-3002 | Start Date*: 2007-02-14 | |||||||||||
Sponsor Name:Johnson & Johnson Pharamceutical Research & Development, L.L.C. | |||||||||||||
Full Title: A Randomized, Double-Blind, Active- And Placebo-Controlled, Parallel Group, Multicenter Study To Evaluate The Efficacy And Safety of Multiple Doses of CG5503 Immediate Release Formulation In Subjec... | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004269-96 | Sponsor Protocol Number: IG8801CLBP201 | Start Date*: 2016-02-24 | |||||||||||
Sponsor Name:Gador S.A. | |||||||||||||
Full Title: A 24 weeks multicentre, randomized, double-blind, placebo-controlled, parallel group, study to evaluate the efficacy, safety and tolerability of intravenous IG-8801 20 mg and 40 mg in subjects with... | |||||||||||||
Medical condition: non-specific Chronic Low Back Pain persisting for at least 3 months | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002943-11 | Sponsor Protocol Number: KF5503/60 | Start Date*: 2013-02-25 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Evaluation of the effectiveness, safety, and tolerability of tapentadol PR versus oxycodone/naloxone PR in non-opioid pre-treated subjects with uncontrolled severe chronic low back pain with a neur... | ||||||||||||||||||
Medical condition: Severe chronic low back pain with a neuropathic pain component | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) IT (Completed) AT (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022873-32 | Sponsor Protocol Number: MRK008b-2010 | Start Date*: 2010-12-14 |
Sponsor Name:Analgesic Solutions | ||
Full Title: An Enriched Enrollment, Double Blind, Placebo-Controlled, Parallel Group, Randomized Withdrawal Trial to Evaluate the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients with Mode... | ||
Medical condition: Patients with Neuropathic Pain. In the first instance, the investigator will aim to recruit patients with post herpetic neuralgia. If insufficient patients with post herpetic neuralgia are recruite... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006042-13 | Sponsor Protocol Number: MEDI-TOLP-01 | Start Date*: 2022-03-28 | |||||||||||
Sponsor Name:MEDITOP Gyógyszeripari Kft. | |||||||||||||
Full Title: A randomized double blind placebo controlled multicenter study to assess the efficacy and tolerability of tolperisone as add on treatment with standardized NSAID of acute non specific low back pain. | |||||||||||||
Medical condition: Acute, non-specific low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000103-20 | Sponsor Protocol Number: 202000638 | Start Date*: 2021-07-15 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: An explorative randomized, placebo-controlled and double-blind intervention crossover study: Transvamix (100mg/mL THC / 50mg/mL CBD) to treat chronic pain in Epidermolysis Bullosa | ||
Medical condition: Genetic Epidermolysis Bullosa | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002092-42 | Sponsor Protocol Number: KF6010/01 | Start Date*: 2011-11-04 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Evaluation of the efficacy, tolerability, and safety of 7 days of treatment with GRT6010 or pregabalin in comparison to placebo in subjects with peripheral neuropathic pain. | |||||||||||||
Medical condition: mononeuropathic pain due to post-herpetic neuralgia, post-operative neuropathic pain, or traumatic nerve injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) DE (Completed) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001042-10 | Sponsor Protocol Number: VX16-150-102 | Start Date*: 2018-01-17 | ||||||||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | ||||||||||||||||||
Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, 6-Week, Parallel-design Study of the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy | ||||||||||||||||||
Medical condition: Pain Caused by Small Fiber Neuropathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) NL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003621-87 | Sponsor Protocol Number: COIL | Start Date*: 2007-02-21 | |||||||||||
Sponsor Name:Merck Selbstmedikation GmbH | |||||||||||||
Full Title: Double-blind, placebo-controlled, randomised, parallel-groups, multi-centre clinical trial for the evaluation of efficacy and safety of an ointment of comfrey extract in comparison to placebo in th... | |||||||||||||
Medical condition: Acute upper and low back pain as described in the note for guidance on clinical investigation of medical products for treatment of Nociceptive Pain. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003602-31 | Sponsor Protocol Number: TRM-201-HA-301 | Start Date*: 2021-12-15 |
Sponsor Name:Tremeau Pharmaceuticals, Inc. | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase III Study with a Long-Term, Open-label Extension to Evaluate the Efficacy and Safety of TRM-201 (Rofecoxib) in Patients with He... | ||
Medical condition: Hemophilic Arthropathy | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007405-37 | Sponsor Protocol Number: 1497/08 | Start Date*: 2009-03-07 | ||||||||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | ||||||||||||||||||
Full Title: Multicenter, not-for-profit study to evaluate tolerability, safety of tramadol once-a-day in older patients with dementia and difficulty to verbalize | ||||||||||||||||||
Medical condition: Pain in older patients with dementia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005278-86 | Sponsor Protocol Number: 147(Z)WO20157 | Start Date*: 2021-06-14 | ||||||||||||||||
Sponsor Name:AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. | ||||||||||||||||||
Full Title: Efficacy and safety of the combination of ibuprofen and paracetamol versus ibuprofen in monotherapy in acute Low Back Pain (LBP) | ||||||||||||||||||
Medical condition: Low Back Pain (LBP) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003278-93 | Sponsor Protocol Number: KF5503/34-R331333-PAI-3004 | Start Date*: 2007-01-31 | |||||||||||
Sponsor Name:Johnson & Johnson Pharamceutical Research & Development, L.L.C. | |||||||||||||
Full Title: Randomized, Double-Blind, Active-Control, Parallel Group, 90-Day Safety Study of CG5503 Immediate Release or Oxycodone Immediate Release in Subjects With Chronic Pain from Low Back Pain or Osteoart... | |||||||||||||
Medical condition: moderate to severe pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004255-38 | Sponsor Protocol Number: cnp-MS-0601/MC-2006-01 | Start Date*: 2007-01-05 | |||||||||||
Sponsor Name:Bionorica research GmbH | |||||||||||||
Full Title: Multi-centre, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of the pain relieving effect of Dronabinol in patients with multiple sclerosis associated wit... | |||||||||||||
Medical condition: Patients with multiple sclerosis associated with central neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DK (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003890-27 | Sponsor Protocol Number: 69.52 | Start Date*: 2012-09-26 |
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | ||
Full Title: A multi-centre, double-blind, randomised, parallel group study to assess the efficacy and safety of multiple doses of topically applied hyperemisation-inducing ointment (2 cm ointment line per appl... | ||
Medical condition: Acute low back pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000023-33 | Sponsor Protocol Number: PIR-BO-11-001 | Start Date*: 2011-11-02 | |||||||||||
Sponsor Name:S.P.A. ITALIANA LABORATORI BOUTY | |||||||||||||
Full Title: Clinical trial to evaluate, in patient suffering of neck pain the therapeutic equivalence, tolerability and satisfaction of subjects treated by medicated plaster containing piroxicam or diclofenac. | |||||||||||||
Medical condition: cervical pain of osteoarthritic origin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002751-15 | Sponsor Protocol Number: ST-001 | Start Date*: 2019-04-20 | |||||||||||
Sponsor Name:Hope Pharmaceuticals Ltd | |||||||||||||
Full Title: A Phase 3, Intravenous Sodium Thiosulfate for Acute Calciphylaxis Treatment: A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial | |||||||||||||
Medical condition: Calciphylaxis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004886-15 | Sponsor Protocol Number: MTA:CT4-09-18--Sponsor:18I-Fsg08 | Start Date*: 2019-05-17 | |||||||||||
Sponsor Name:IBSA INSTITUT BIOCHIMIQUE SA | |||||||||||||
Full Title: Evaluation of Treatment Satisfaction, Effectiveness and Tolerability in Subjects treated with Low-dose Diclofenac Epolamine Soft Capsules for Acute, Mild or Moderate Musculoskeletal Pain | |||||||||||||
Medical condition: Patients with acute, mild or moderate musculoskeletal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001874-16 | Sponsor Protocol Number: B3491009 | Start Date*: 2015-07-29 |
Sponsor Name:Pfizer | ||
Full Title: Placebo Controlled, Double Blind Evaluation of the Efficacy and Safety of Ibuprofen 5% Topical Gel for the Treatment of Ankle Sprain | ||
Medical condition: First or second degree ankle sprain | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2012-000402-30 | Sponsor Protocol Number: ESTEVE-SIGM-205 | Start Date*: 2012-06-18 | |||||||||||
Sponsor Name:Laboratorios del Dr. Esteve. S.A | |||||||||||||
Full Title: An exploratory, randomized, double blind, placebo controlled, parallel groups Phase II clinical trial to evaluate the efficacy and safety of E-52862 (400 mg) by oral route, in patients with post-su... | |||||||||||||
Medical condition: Post-surgical neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
